AMBER WATSON: Open Payments
NPI 1043984917 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 56 payments from 14 companies in 2025. Trend: 2023 $343 · 2024 $545 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 22 | $271 |
| Axsome Therapeutics, Inc. | 4 | $112 |
| Neurocrine BioSciences, Inc. | 3 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $96 |
| ABBVIE INC. | 3 | $93 |
| Alkermes, Inc. | 4 | $84 |
| Braeburn Inc. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Orexo US, Inc. | 2 | $32 |
Products named: SUBLOCADE, INGREZZA, CAPLYTA, VRAYLAR, Sunosi, BRIXADI, REXULTI, UZEDY.
Industry payments across CO — which companies pay providers there.
